The potential of chitosan in ocular drug delivery
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
This paper presents an overview of the potential of chitosan-based systems for improving the retention and biodistribution of drugs applied topically onto the eye. Besides its low toxicity and good ocular tolerance, chitosan exhibits favourable biological behaviour, such as bioadhesion- and permeability-enhancing properties, and also interesting physico-chemical characteristics, which make it a unique material for the design of ocular drug delivery vehicles. The review summarizes the techniques for the production of chitosan gels, chitosan-coated colloidal systems and chitosan nanoparticles, and describes their mechanism of action upon contact with the ocular mucosa. The results reported until now have provided evidence of the potential of chitosan gels for enhancing and prolonging the retention of drugs on the eye surface. On the other hand, chitosan-based colloidal systems were found to work as transmucosal drug carriers, either facilitating the transport of drugs to the inner eye (chitosan-coated colloidal systems containing indometacin) or their accumulation into the corneal/conjunctival epithelia (chitosan nanoparticles containing ciclosporin). Finally, the tolerance, toxicity and biodegradation of the carriers under evaluation were reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
Calvo, P., Remu��n-L�pez, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4 · Cited by 1,856
Self-citationChitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Polysaccharide colloidal particles as delivery systems for macromolecules
Janes, K. A., Calvo, P., & Alonso, M. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00123-x · Cited by 900
Self-citationEncyclopedia Of Controlled Drug Delivery
Mathiowitz, E. (1999) · Medical Entomology and Zoology · Cited by 855
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Self-citationChitosan: some pharmaceutical and biological aspects - an update
Singla, A. K., & Chawla, M. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776441 · Cited by 784
Chitosan: A Unique Polysaccharide for Drug Delivery
Felt, O., Buri, P., & Gurny, R. (1998) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049809089942 · Cited by 769
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 765
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
Cited by
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Chitosan-based hydrogels for controlled, localized drug delivery
Bhattarai, N., Gunn, J., & Zhang, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.019 · Cited by 2,451
The use of mucoadhesive polymers in ocular drug delivery
LUDWIG, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.005 · Cited by 922
The safety of chitosan as a pharmaceutical excipient
Baldrick, P. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2009.09.015 · Cited by 569
Chitosan Chemistry: Relevance to the Biomedical Sciences
Muzzarelli, R. A. A., & Muzzarelli, C. (2005) · Advances in Polymer Science · doi:10.1007/b136820 · Cited by 555
Azmana, M., Mahmood, S., Hilles, A. R., Rahman, A., Arifin, M. A. B., & Ahmed, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.023 · Cited by 465
Chitosan-Based Nanoparticles as Effective Drug Delivery Systems—A review
Jafernik, K., Ładniak, A., Blicharska, E., Czarnek, K., Ekiert, H., Wiącek, A. E., & Szopa, A. (2023) · Molecules · doi:10.3390/molecules28041963 · Cited by 460
Applications of nanoparticles in ophthalmology
Diebold, Y., & Calonge, M. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.002 · Cited by 392
Das, A., Ringu, T., Ghosh, S., & Pramanik, N. (2023) · Polymer Bulletin · doi:10.1007/s00289-022-04443-4 · Cited by 380
A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery
Gratieri, T., Gelfuso, G. M., Rocha, E. M., Sarmento, V. H., de Freitas, O., & Lopez, R. F. V. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.011 · Cited by 376
Recent Advances in Chitosan-Based Applications—A Review
Thambiliyagodage, C., Jayanetti, M., Mendis, A., Ekanayake, G., Liyanaarachchi, H., & Vigneswaran, S. (2023) · Materials · doi:10.3390/ma16052073 · Cited by 374
Chitosan-based nanostructures: A delivery platform for ocular therapeutics
de la Fuente, M., Raviña, M., Paolicelli, P., Sanchez, A., Seijo, B., & Alonso, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.026 · Cited by 354
Self-citationNanoparticles for drug delivery to the anterior segment of the eye
Janagam, D. R., Wu, L., & Lowe, T. L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.001 · Cited by 341
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel
Kim, J.-H., Kim, Y.-S., Kim, S., Park, J. H., Kim, K., Choi, K., Chung, H., Jeong, S. Y., Park, R.-W., Kim, I.-S., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.013 · Cited by 313
de Salamanca, A. E., Diebold, Y., Calonge, M., Garci´a-Vazquez, C., Callejo, S., Vila, A., & Alonso, M. J. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0495 · Cited by 286
Self-citationUpadhyaya, L., Singh, J., Agarwal, V., & Tewari, R. P. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.043 · Cited by 276
Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP)
Diebold, Y., Jarrín, M., Sáez, V., Carvalho, E. L. S., Orea, M., Calonge, M., Seijo, B., & Alonso, M. J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.028 · Cited by 273
Self-citationOverview of wastewater treatment methods with special focus on biopolymer chitin-chitosan
Sarode, S., Upadhyay, P., Khosa, M. A., Mak, T., Shakir, A., Song, S., & Ullah, A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.089 · Cited by 267
Polymeric micelles in mucosal drug delivery: challenges towards clinical translation
Sosnik, A., & Menaker Raskin, M. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.01.003 · Cited by 154
Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone
Xu, X., Sun, L., Zhou, L., Cheng, Y., & Cao, F. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115356 · Cited by 153
Grimaudo, M. A., Pescina, S., Padula, C., Santi, P., Concheiro, A., Alvarez-Lorenzo, C., & Nicoli, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1597848 · Cited by 78
Metadata
- Authors
- Alonso, M. J., & Sánchez, A.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11-01
- Volume
- 55
- Issue
- 11
- Pages
- 1451-1463
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2077799930
- Cited by
- 352
- References
- 56
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.